Navigation Links
Wyeth Announces Results of the Company's Offer Relating to Holder Right to Surrender Convertible Debentures
Date:7/15/2009

l products and our anticipated new product introductions; the highly regulated nature of our business; product liability, intellectual property and other litigation risks and environmental liabilities; the outcome of government investigations; uncertainty regarding our intellectual property rights and those of others; difficulties associated with, and regulatory compliance with respect to, manufacturing of our products; risks associated with our strategic relationships; global economic conditions; interest and currency exchange rate fluctuations and volatility in the credit and financial markets; changes in generally accepted accounting principles; trade buying patterns; the impact of legislation and regulatory compliance; risks and uncertainties associated with global operations and sales; and other risks and uncertainties, including those detailed from time to time in our periodic reports filed with the Securities and Exchange Commission, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual report on Form 10-K, particularly the discussion under the caption "Item 1A, Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2008, which was filed with the Securities and Exchange Commission (SEC) on February 27, 2009. The forward-looking statements in this press release are qualified by these risk factors. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.


'/>"/>
SOURCE Wyeth
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Wyeth Consumer Healthcare Announces the Availability of New Centrum Ultra Line of Multivitamins Specially Formulated For Women and Men
2. Wyeths Prevenar 13* Receives First Approval
3. Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
4. Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders
5. New Therapies, Including Novel Biologic Agents from Elan/Wyeth and Eli Lilly, Will Drive Robust 11 Percent Annual Growth In the Alzheimers Disease Market
6. Metastorm Customer, Wyeth Pharmaceuticals, Wins CIO 100 Award for BPM Project
7. DIA 45th Annual Meeting Features Sessions Highlighting Wyeth v. Levine and Pandemic Influenza
8. Wyeth Donates $100,000 to ASCO Cancer Foundation(R) to Support Cancer Prevention and Care
9. U.S. and 16 States Join Suits Against Pharmaceutical Giant, Wyeth
10. Wyeth Reports Earnings Results for the 2009 First Quarter
11. Gene Network Sciences Names Former Wyeth President of R&D Robert Ruffolo to SAB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 2014 Daily Gossip writes in its Xtreme ... as the fastest fat loss program ever developed. It promises ... month. , There is no wonder after all that this ... time. The new nutrition and workout fat loss program was ... , According to the author of this fat loss ...
(Date:10/31/2014)... Lake City, UT (PRWEB) October 31, 2014 ... announce the new Activz Silver line offering ... and cleansing wipes. For over a century, silver has ... formula found in Activz Silver products is the most ... U.S. patents, has a unique chemical structure that supports ...
(Date:10/31/2014)... In terms of duration of treatment and cost, ... from accelerated partial breast irradiation (APBI) with proton ... new research from The University of Texas MD ... a cost analysis study based on typical patient ... allowable charges for eight different types of partial ...
(Date:10/31/2014)... 31, 2014 The Suspension Revolution review ... program was developed by Dan Long, a suspension training ... a fitness professional and life coach. The author of ... toned muscles is not impossible , The Suspension Revolution ... training. Suspension training promises efficiency when it comes to ...
(Date:10/31/2014)... FindSurrogateMother.com conveys a refreshing ... life — building a family through surrogacy. The company ... donors with hopeful intended parents in turn generating thousands ... a collective aptitude of surrogate mothers, intended parents, egg ... clinics that help provide these connections — and a ...
Breaking Medicine News(10 mins):Health News:Xtreme Fat Loss Diet Review Reveals How to Transform Your Body in 25 Days 2Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 2Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 4Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 2Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 3Health News:Suspension Revolution Review Reveals Dan Long's New Suspension Workout Plan 2Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 2Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 3
... Hodgkin's disease are found to have a higher risk of ... given for the same, a new research has concluded. //, ... and the other immune system organs. Researchers found that women ... if they survived Hodgkin's lymphoma. Dr Lois B. Travis, from ...
... based on monoclonal antibodies (mAbs) are fare more likely ... According to a study completed by // consultancy Propagate ... to be profitable. That means mAbs are recouping more ... billion cost of development and marketing. By comparison, the ...
... increased risk of HIV during pregnancy because of ... because of the physiological changes during gestation. Irrespective ... that rates of HIV acquisition are significantly higher ... important implications for HIV prevention, both to protect ...
... nanoparticles are potential and very practical agents in ... San Francisco and Georgia Institute of Technology, writing ... the efficiency of gold nanospheres as photothermal agent ... cells that overexpress EGFR, a clinically related cancer ...
... true for the scientists who been working hard for the ... take an extra step ahead as it is likely to ... as their offspring, are safe to eat., ,Canada ... Canadian Scientists having proved themselves following the success regarding Starbuck, ...
... Early Online Publication, released on the 5th of October, ... chronic diseases, has a comprehensive report on the threat ... // by Union Health Minister Dr Anbumani Ramadoss, the ... growing challenge of chronic diseases in India was highlighted, ...
Cached Medicine News:Health News:Therapeutic Monoclonal Antibody Production Is More Profitable Than Small Molecule Drugs 2Health News:Women might be at increased risk of HIV during pregnancy 2Health News:Gold Nanoparticles: Agents For Noninvasive Cancer Therapy 2Health News:Strategies to prevent the rising tide of the epidemic of chronic diseases 2
(Date:10/31/2014)... NEW YORK , October 31, 2014 ... regarding Celgene Corporation (NASDAQ: CELG ), Bristol-Myers ... Inc. (NYSE: UNH ), Sanofi SA (NYSE: ... Private wealth members receive these notes ahead of publication. ... http://www.analystsreview.com/7593-100free . , ,-- ,Celgene Corporation Research Reports ...
(Date:10/31/2014)... VIEW, Calif. , Oct. 31, 2014 ... lateral sclerosis (ALS) patients initiate text and email messages ... upon a patent-pending technology invented by ThynkWare,s founder, ... assistant on a smartphone device. This technology allows users ... using only the power of thought. ThynkWare ...
(Date:10/31/2014)... MELBOURNE, Australia and BARCELONA , ... Pty Ltd (Multigate) was found to infringe two Australian patents ... offering for sale in Australia safety ... of 17.10.14 in Federal Court of Australia ... at http://www.austlii.edu.au/au/cases/cth/FCA/2014/1110.html . In the detailed ...
Breaking Medicine Technology:Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 2Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 3Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 4Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 5Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 6ThynkWare Speech Helps Those with ALS and Locked-In Syndrome Translate Thought to Speech on Their Smartphone Devices 2B. Braun Wins Patent Disputes Against Poly Medicure Ltd's Australian Distributor Multigate Medical Devices Pty. Ltd. and Spanish Distributor Dextromédica S. L. 2
... 2010 Reportlinker.com announces that a new market ... 2010 Pharmaceuticals Research Review ... FOREWORD The economic slowdown has accentuated the fault lines ... from the large pharma companies, coupled with the ...
... Reportlinker.com announces that a new market research report ... Technologies and Global Markets http://www.reportlinker.com/p0341186/Antiemetics-Technologies-and-Global-Markets.html ... nearly $2.4 billion in 2009.  There was a little ... to weakened economy and competition within brands and generics.  ...
Cached Medicine Technology:Reportlinker Adds 2010 Pharmaceuticals Research Review 2Reportlinker Adds 2010 Pharmaceuticals Research Review 3Reportlinker Adds 2010 Pharmaceuticals Research Review 4Reportlinker Adds 2010 Pharmaceuticals Research Review 5Reportlinker Adds 2010 Pharmaceuticals Research Review 6Reportlinker Adds 2010 Pharmaceuticals Research Review 7Reportlinker Adds 2010 Pharmaceuticals Research Review 8Reportlinker Adds 2010 Pharmaceuticals Research Review 9Reportlinker Adds 2010 Pharmaceuticals Research Review 10Reportlinker Adds 2010 Pharmaceuticals Research Review 11Reportlinker Adds 2010 Pharmaceuticals Research Review 12Reportlinker Adds 2010 Pharmaceuticals Research Review 13Reportlinker Adds 2010 Pharmaceuticals Research Review 14Reportlinker Adds Antiemetics: Technologies and Global Markets 2Reportlinker Adds Antiemetics: Technologies and Global Markets 3Reportlinker Adds Antiemetics: Technologies and Global Markets 4Reportlinker Adds Antiemetics: Technologies and Global Markets 5Reportlinker Adds Antiemetics: Technologies and Global Markets 6Reportlinker Adds Antiemetics: Technologies and Global Markets 7Reportlinker Adds Antiemetics: Technologies and Global Markets 8Reportlinker Adds Antiemetics: Technologies and Global Markets 9Reportlinker Adds Antiemetics: Technologies and Global Markets 10Reportlinker Adds Antiemetics: Technologies and Global Markets 11Reportlinker Adds Antiemetics: Technologies and Global Markets 12Reportlinker Adds Antiemetics: Technologies and Global Markets 13
... The Auto Suture™ ... inclusive of five (5) ... application in a variety ... urologic, colorectal and other ...
... RETRACT™ 12 mm instrument has application in ... and other endoscopic procedures for retracting internal ... , ,The ENDO PADDLE RETRACT™ instrument ... distal end of the instrument and is ...
... Introducing the widest offering of single-use instruments ... and long 43cm lengths for Bariatric Surgery. ... , Extended insulation covers the pivot points to ... , A 4mm universal cord, which eliminates gapping ...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Medicine Products: